Skip to main content
. 2017 Aug 24;8(44):77369–77384. doi: 10.18632/oncotarget.20484

Table 4. Discriminant analysis results for miR-18a, miR-21 and miR-27a expression profiles.

Original group Predicted group membership Total
Controls N (%) Invasive BC N (%)
Controls N (%) 13 (59.1) 9 (40.9) 22 (100.0)
Invasive BC N (%) 4 (4.7) 81 (95.3) 85 (100.0)

87.9% of original grouped cases correctly classified. For each miRNA, only samples analyzed successfully were included into statistical analysis.

BC, breast cancer.